Literature DB >> 12917758

Pattern of lymphatic spread of Barrett's cancer.

Marcus Feith1, Hubert J Stein, J Rüdiger Siewert.   

Abstract

As in squamous cell esophageal cancer, the presence and number of lymph node metastases constitutes the major prognostic factor in patients with adenocarcinoma of the distal esophagus (the so-called Barrett's cancer) who have had complete tumor resection (R0 resection). In contrast to squamous cell esophageal cancer, however, lymphatic spread in patients with Barrett's cancer appears to follow certain rules. Lymphatic spread is closely correlated with the pT category of the primary tumor; it starts only after infiltration of the basal membrane, and initially it is limited to the regional lymph nodes. Lymph node metastases at distant locations-i.e., the upper mediastinum and the celiac axis-are found almost exclusively in patients with multiple positive regional nodes. Skipping of regional lymph node stations occurs in less than 5% of the patients. These observations set the stage for individualized and tailored lymphadenectomy strategies. The sentinel lymphadenectomy concept may be applicable to patients with early Barrett's cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12917758     DOI: 10.1007/s00268-003-7060-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  29 in total

Review 1.  Barrett's cancer: indications, extent, and results of surgical resection.

Authors:  J R Siewert; H J Stein
Journal:  Semin Surg Oncol       Date:  1997 Jul-Aug

2.  The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction.

Authors:  S M Dresner; P J Lamb; M K Bennett; N Hayes; S M Griffin
Journal:  Surgery       Date:  2001-01       Impact factor: 3.982

3.  Transhiatal esophagectomy: clinical experience and refinements.

Authors:  M B Orringer; B Marshall; M D Iannettoni
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

4.  Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction.

Authors:  C van de Ven; P De Leyn; W Coosemans; D Van Raemdonck; T Lerut
Journal:  Eur J Cardiothorac Surg       Date:  1999-06       Impact factor: 4.191

5.  Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction.

Authors:  J D Mueller; H J Stein; T Oyang; S Natsugoe; M Feith; M Werner; J Rüdiger Siewert
Journal:  Cancer       Date:  2000-11-01       Impact factor: 6.860

Review 6.  Individualized surgical strategies for cancer of the esophagogastric junction.

Authors:  H J Stein; M Feith; J R Siewert
Journal:  Ann Chir Gynaecol       Date:  2000

7.  Localization of initial lymph node metastasis from carcinoma of the thoracic esophagus.

Authors:  T Matsubara; M Ueda; S Kaisaki; J Kuroda; C Uchida; N Kokudo; T Takahashi; T Nakajima; A Yanagisawa
Journal:  Cancer       Date:  2000-11-01       Impact factor: 6.860

8.  Limited resection for early adenocarcinoma in Barrett's esophagus.

Authors:  H J Stein; M Feith; J Mueller; M Werner; J R Siewert
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

9.  Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status.

Authors:  T W Rice; G Zuccaro; D J Adelstein; L A Rybicki; E H Blackstone; J R Goldblum
Journal:  Ann Thorac Surg       Date:  1998-03       Impact factor: 4.330

10.  Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.

Authors:  Mohamad A Eloubeidi; Renee Desmond; Miguel R Arguedas; Carolyn E Reed; C Mel Wilcox
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

View more
  41 in total

Review 1.  Endoscopic management of Barrett's esophagus: advances in endoscopic techniques.

Authors:  Ali Azarm; Ismet Lukolic; Meenal Shukla; Ronald Concha-Parra; Frank Gress
Journal:  Dig Dis Sci       Date:  2012-07-04       Impact factor: 3.199

Review 2.  Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?

Authors:  Vani J A Konda; Mark K Ferguson
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

3.  Endoscopic resection techniques and ablative therapies for Barrett's neoplasia.

Authors:  Jacobo Ortiz-Fernández-Sordo; Adolfo Parra-Blanco; Alejandro García-Varona; María Rodríguez-Peláez; Erika Madrigal-Hoyos; Irving Waxman; Luis Rodrigo
Journal:  World J Gastrointest Endosc       Date:  2011-09-16

4.  Feasibility study of sentinel lymph node biopsy in esophageal cancer with conservative lymphadenectomy.

Authors:  Sarah K Thompson; Dylan Bartholomeusz; Peter G Devitt; Peter J Lamb; Andrew R Ruszkiewicz; Glyn G Jamieson
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

Review 5.  Management of high-grade dysplasia.

Authors:  Francesco Palazzo; Piero M Fisichella; Marco G Patti
Journal:  Curr Gastroenterol Rep       Date:  2008-06

Review 6.  Endotherapy for Barrett's esophagus with high-grade dysplasia and intramucosal carcinoma.

Authors:  Drew B Schembre
Journal:  J Gastrointest Surg       Date:  2009-03-26       Impact factor: 3.452

7.  Results of a multimodal therapy in patients with stage IV Barrett's adenocarcinoma.

Authors:  Matthias Schauer; Hubert Stein; Florian Lordick; Marcus Feith; Joerg Theisen; Joerg Ruediger Siewert
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

Review 8.  [Surgical strategy for early stage carcinoma of the esophagus].

Authors:  N Niclauss; M Chevallay; J L Frossard; S P Mönig
Journal:  Chirurg       Date:  2018-05       Impact factor: 0.955

Review 9.  Surgical management of esophagogastric junction tumors.

Authors:  Burkhard H A von Rahden; Hubert J Stein; J Rüdiger Siewert
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

Review 10.  [Neoadjuvant therapy in the upper gastro-intestinal tract. Modern strategies for Barrett's cancer].

Authors:  H J Stein; M Feith; J R Siewert
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.